Prothena Plc Valuation
| PRTA Stock | USD 8.67 0.03 0.35% |
At this time, the company appears to be undervalued. Prothena plc holds a recent Real Value of $11.41 per share. The prevailing price of the company is $8.67. Our model determines the value of Prothena plc from analyzing the company fundamentals such as Shares Outstanding of 53.83 M, return on equity of -0.64, and Shares Owned By Institutions of 88.60 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Prothena Plc's valuation include:
Price Book 1.5757 | Enterprise Value | Enterprise Value Ebitda (3.58) | Price Sales 48.1935 | Forward PE 11.0619 |
Undervalued
Today
Please note that Prothena Plc's price fluctuation is not too volatile at this time. Calculation of the real value of Prothena plc is based on 3 months time horizon. Increasing Prothena Plc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Prothena Plc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Prothena Stock. However, Prothena Plc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.67 | Real 11.41 | Target 20.5 | Hype 8.76 | Naive 9.21 |
The real value of Prothena Stock, also known as its intrinsic value, is the underlying worth of Prothena plc Company, which is reflected in its stock price. It is based on Prothena Plc's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Prothena Plc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Prothena plc helps investors to forecast how Prothena stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Prothena Plc more accurately as focusing exclusively on Prothena Plc's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Prothena Plc's intrinsic value based on its ongoing forecasts of Prothena Plc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Prothena Plc's closest peers. If more than one evaluation category is relevant for Prothena Plc we suggest using both methods to arrive at a better estimate.
Prothena Plc Cash |
|
Prothena Revenue by Product
Prothena Plc Total Value Analysis
Prothena plc is at this time anticipated to have valuation of 143.06 M with market capitalization of 466.71 M, debt of 13.86 M, and cash on hands of 508.8 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Prothena Plc fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
143.06 M | 466.71 M | 13.86 M | 508.8 M |
Prothena Plc Investor Information
About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prothena plc has Price/Earnings To Growth (PEG) ratio of 0.8. The entity recorded a loss per share of 4.53. The firm had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Prothena Plc's historical financial statements, Prothena plc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Prothena Plc Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Prothena Plc has an asset utilization ratio of 2.96 percent. This suggests that the Company is making $0.0296 for each dollar of assets. An increasing asset utilization means that Prothena plc is more efficient with each dollar of assets it utilizes for everyday operations.Prothena Plc Profitability Analysis
Based on the measurements of profitability obtained from Prothena Plc's financial statements, Prothena plc may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Prothena Plc's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -36.5 M | Current Value -21.6 M | Quarterly Volatility 33.3 M |
For Prothena Plc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Prothena plc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Prothena Plc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Prothena Plc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Prothena Plc over time as well as its relative position and ranking within its peers.
Prothena Plc Earnings per Share Projection vs Actual
By analyzing Prothena Plc's earnings estimates, investors can diagnose different trends across Prothena Plc's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Prothena plc is based on EPS before non-recurring items and includes expenses related to employee stock options.Prothena Plc Ownership Allocation
Prothena Plc owns a total of 53.83 Million outstanding shares. The majority of Prothena plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Prothena plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Prothena Plc. Please pay attention to any change in the institutional holdings of Prothena plc as this could imply that something significant has changed or is about to change at the company. Also note that almost four million two hundred nine thousand five hundred five invesors are currently shorting Prothena Plc expressing very little confidence in its future performance.Prothena Plc Profitability Analysis
The company reported the previous year's revenue of 9.68 M. Net Loss for the year was (244.09 M) with loss before overhead, payroll, taxes, and interest of (125.17 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Prothena Plc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Prothena Plc and how it compares across the competition.
About Prothena Plc Valuation
The stock valuation mechanism determines Prothena Plc's current worth on a weekly basis. Our valuation model uses a comparative analysis of Prothena Plc. We calculate exposure to Prothena Plc's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Prothena Plc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 155.4 M | 163.2 M | |
| Pretax Profit Margin | (20.74) | (21.78) | |
| Operating Profit Margin | (19.06) | (20.01) | |
| Net Loss | (25.21) | (26.47) | |
| Gross Profit Margin | (99.81) | (104.80) |
Prothena Plc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 53.8 M | |
| Forward Price Earnings | 11.0619 |
Prothena Plc Current Valuation Indicators
Valuation refers to the process of determining the present value of Prothena plc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Prothena we look at many different elements of the entity such as Prothena's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Prothena Plc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Prothena Plc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Prothena Plc's worth.Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |